Mirae Asset Global Investments Co., Ltd. Savara Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Savara Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,126 shares of SVRA stock, worth $18,319. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,126Holding current value
$18,319% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SVRA
# of Institutions
145Shares Held
147MCall Options Held
280KPut Options Held
798K-
Nea Management Company, LLC Timonium, MD24.5MShares$109 Million9.31% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$64.7 Million12.01% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$54.9 Million7.46% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.16MShares$36.2 Million1.94% of portfolio
-
Black Rock Inc. New York, NY8.03MShares$35.7 Million0.0% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $506M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.